Ligand Pharmaceuticals Inc. (LGND) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained roughly 27% since Nov 7.
This healthcare company has seen a mixed track record when it comes to estimate revision with an upward and downward revision apiece in the past one month. The Zacks Consensus Estimate hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Ligand Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks in the same industry include Jazz Pharmaceuticals Public Limited Company (JAZZ), Lannett Company, Inc. (LCI) and Questcor Pharmaceuticals, Inc. (QCOR). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
LIGAND PHARMACEUTICALS (LGND): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
LANNETT CO INC (LCI): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research